Gynecologic Cancer InterGroup (GCIG) consensus review for cervical adenocarcinoma

Hiroyuki Fujiwara, Harushige Yokota, Bradley Monk, Isabelle Treilleux, Mojgan Devouassoux-Shisheboran, Alison Davis, Jae Weon Kim, Sven Mahner, Michael Stany, Sandro Pignata, Isabelle Ray-Coquard, Keiichi Fujiwara

Research output: Contribution to journalArticlepeer-review

Abstract

Cervical adenocarcinoma is known to be less common than squamous cell carcinoma of the cervix comprising approximately 25% of all cervical carcinomas. Differences in associated human papillomavirus types, patterns of spread, and prognosis call for treatments that are not always like those for squamous cancers. In this review, we report a consensus developed by the Gynecologic Cancer InterGroup surrounding cervical adenocarcinoma for epidemiology, pathology, treatment, and unanswered questions. Prospective clinical trials are needed to help develop treatment guidelines.

Original languageEnglish
Pages (from-to)S96-S101
JournalInternational Journal of Gynecological Cancer
Volume24
Issue number9
DOIs
Publication statusPublished - Nov 1 2014

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Gynecologic Cancer InterGroup (GCIG) consensus review for cervical adenocarcinoma'. Together they form a unique fingerprint.

Cite this